Objective: To determine the association between post-traumatic stress disorder (PTSD) symptoms and health-related quality of life (HRQoL) of post-COVID-19 patients in primary care.
Design: Cross-sectional, multicenter, random probability sampling study.
Location: Primary care centers in Ica-Peru.
Participants: Six hundred and thirty-six patients with previous diagnosis of COVID-19.
Main Measures: The variable PTSD symptoms was measured with the COVID-19-PTSD questionnaire and HRQOL with the EuroQol scale (EQ-5D). Sociodemographic and health factors including post-COVID-19 syndrome were analyzed. A descriptive analysis was performed and crude and adjusted prevalence ratios (PR) were calculated using generalized linear models of the Poisson family to search for associations between variables.
Results: Of the participants, 21.4% presented symptoms of PTSD; 33.6% symptoms of dysphoric and anxious arousal; 22.3% intrusion, avoidance and negative affect; 22.6% anhedonia; and 23.6% externalizing behavior. 50.3% revealed at least one component of HRQoL affected; 35.5% problems linked to anxiety/depression; 34.9% pain/discomfort; 11% daily activity; 10.7% mobility and 6.6% self-care. The presence of PTSD symptoms was associated with the HRQoL affected (PR=2.46: 95% CI: 2.19-2.78). Also, certain sociodemographic and health variables were associated with PTSD symptoms and affected HRQoL.
Conclusions: PTSD symptoms, increase the probability of affecting the patient's HRQoL post COVID-19. There are potentially modifiable sociodemographic and health variables that could decrease PTSD symptoms and improve HRQoL.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420717 | PMC |
http://dx.doi.org/10.1016/j.aprim.2022.102460 | DOI Listing |
Criminal victimization is associated with an increased risk of violent offending, which can be motivated by revenge. Experiencing revenge desire could also be harmful for crime victims' mental health. To limit revenge's harmful effects, researchers have examined the predictors of revenge desire and attitudes.
View Article and Find Full Text PDFAm J Physiol Regul Integr Comp Physiol
January 2025
Division of Physical Therapy and Rehabilitation Science, Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, MN.
Arterial stiffness is a well-known risk factor for cardiovascular disease. Although estradiol (E2) is known to be cardioprotective, the available data point to a growing cardiovascular disease risk in women before menopause due to post-traumatic stress disorder (PTSD). The present study aimed to investigate the effects of E2 on arterial compliance in trauma-exposed premenopausal women, with and without a clinical diagnosis PTSD.
View Article and Find Full Text PDFActa Psychol (Amst)
January 2025
Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland.
Post-traumatic stress disorder (PTSD) is a psychiatric condition triggered by experiencing or witnessing traumatic events, such as death, serious injury, or threats to oneself or others. Affecting 5-10 % of the population, PTSD is often underreported due to the reluctance of individuals to disclose personal traumatic experiences. This study explore the effectiveness of a digital (electronic mental health and psychosocial support) and psychologist-led intervention in mitigating PTSD symptoms.
View Article and Find Full Text PDFRationale: Patients who experience seizures, including PNES, are usually advised to discontinue driving, or have their driving privileges revoked until a determined period of seizure-freedom is achieved. In this retrospective study, patients with PNES who requested driving privileges or reported having resumed driving were compared to those who did not on measures of depression, anxiety, PTSD, and cognitive flexibility/motor speed.
Methods: DiagnosisofPNESwasconfirmedwithvideo-EEG.
PLoS One
January 2025
Interventional Psychiatry Program, St. Michael's Hospital, Toronto, Ontario, Canada.
Background: Posttraumatic stress disorder (PTSD) affects 3.9% of the general population. While massed cognitive processing therapy (CPT) has demonstrated efficacy in treating chronic PTSD, a substantial proportion of patients still continue to meet PTSD criteria after treatment, highlighting the need for novel therapeutic approaches.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!